The FDA has placed its most serious warning - called a Boxed Warning - on the non-hormonal drug fezolinetant, which is sold ...
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Liver cirrhosis is a serious condition where healthy liver tissue is replaced with scar tissue, making it harder for the ...
The US Food and Drug Administration has placed its most serious warning — a so-called black-box warning — on a drug used to ...
Sophie Casey, 28, from Leeds was diagnosed with stage 4B Ovarian cancer in October, after several visits to her GP, a ...
The EMA’s Committee for Medicinal Products for Human Use (CHMP) determined that expected clinical benefits of seladelpar include delayed development of liver fibrosis and cirrhosis, potentially ...
Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis ...